✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Bal Pharma Ltd.

BALPHARMA

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹117 Cr.
P/E
17.10

Bal Pharma Ltd.

  • Bal Pharma
  • Tyche Inds
  • Smruthi Organics
  • TJI Pharma - Small Cap

FAQs on Bal Pharma Ltd. Shareprice

Bal Pharma has given lower returns compared to its competitors.
Bal Pharma has grown at ~-3.5% over the last 8yrs while peers have grown at a median rate of -1.15%

Bal Pharma is not expensive.
Latest PE of Bal Pharma is 17.1, while 3 year average PE is 32.99.
Also latest EV/EBITDA of Bal Pharma is 9.68 while 3yr average is 10.67.

View FAQ's On Business

Growth Table

  • Bal Pharma Ltd.
  • Tyche Inds
  • Smruthi Organics

Balance Sheet

  • Bal Pharma Ltd.
  • Tyche Inds
  • Smruthi Organics

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Bal Pharma Ltd.
  • Tyche Inds
  • Smruthi Organics

Cash Flow

  • Bal Pharma Ltd.
  • Tyche Inds
  • Smruthi Organics

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Bal Pharma Ltd.
  • Tyche Inds
  • Smruthi Organics

Quarterly Results

  • Bal Pharma Ltd.
  • Tyche Inds
  • Smruthi Organics

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Bal Pharma Ltd. Financials

Bal Pharma balance sheet is weak and might have solvency issues

Yes, The net debt of Bal Pharma is increasing.
Latest net debt of Bal Pharma is ₹146 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹134 Crs.

No, profit is decreasing.
The profit of Bal Pharma is ₹6.86 Crs for TTM, ₹7.22 Crs for Mar 2025 and ₹7.39 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Bal Pharma latest dividend payout ratio is 26.48% and 3yr average dividend payout ratio is 37.71%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech